Open original FDA record ↗Recall record
- FDA identifier
- Z-3017-2018
- Company in FDA record
- Remel Inc
- FDA record creation date
- Sep 7, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Products have intermittently failed performance testing during stability studies with various anaerobic microorganisms.
Source facts
- Action
- The firm initiated the recall by letter on 08/13/2018. The firm directed the consignee to you inspect their stock and destroy any remaining inventory of the lots listed above and contact Customer Services or your local distributor regarding replacement. They also requested that the consignee review results and laboratory reporting associated with use of the listed lots and consider retesting and/or seek appropriate expert advice for further action. The firm instructed the consignee to further distribute the notice to all who need to be aware within your organization or to any organization where the potentially affected products have been transferred. For questions, please contact Technical Services Department at 800-255-6730 (US) or 913-888-0939 (International).
- Initiated
- 2018-08-13
- Root cause
- Under Investigation by firm
- Terminated
- 2019-06-18
- Distribution
- US, Canada, Singapore
- Recall number
- Z-3017-2018
- Recall status
- Terminated
- CDRH record ID
- 166568
- FDA record created
- 2018-09-07
- Recall event number
- 80813